We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

MYOPIA AND PRESBYOPIA EYE DROPS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 to 2028)

Myopia And Presbyopia Eye Drops Market, by Eye Drops (Atropine Drops and Pipeline Products (CSF-1, AGN-190584, Nyxol, UNR844-Cl, PRX-100, MicroLine, and Others)), by Indication (Myopia and Presbyopia), by End User (Hospitals, Ophthalmic Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In: 16 Sep, 2021
Code: CMI4633
Pages: 178
Formats: Excel and PDF
Industry: Pharmaceutical

Presbyopia is an eye disorder, in which one’s eyes gradually lose the ability to see things clearly up close distances. It is a normal part of aging. In addition, myopia is a common eye disorder that cause vision loss, and uncorrected myopia is amongst the leading cause of distance vision impairment worldwide. Several individual studies have shown variations in the prevalence of high myopia and myopia in regions and ethnic groups, and there continues to be uncertainty regarding increasing prevalence of myopia. Moreover, market players are focused on inorganic strategies such as partnerships, in order to increase awareness about childhood myopia which in turn is expected to boost the market growth over the forecast period. For instance, in October 2020, Myopia Profile Pty Ltd and Essilor International entered into a partnership agreement for empowering eye care practitioners with skills, clinical knowledge, and practice in managing childhood myopia. The partnership will also boost public awareness of the consequences of myopia, also called near sightedness, and in addition, this will also encourage parents to have their children’s vision tested.

Market Dynamics

Researchers are focusing on research and development activities for the development of new treatment for myopia and presbyopia, by using new technologies, which is expected to drive growth of the global myopia & presbyopia eye drops market over the forecast period. For instance, in January 2019, Bar-Ilan University’s Institute of Nanotechnology and Advanced Materials (BINA), Israel, developed eye drops called as ‘nanodrops’ for correcting the refractive-related vision problems such as myopia and presbyopia. The eye drops are made up of a synthetic nanoparticle solution and have been tested on pig’s cornea. The researchers reported that the drops treated two kinds of refractive errors: myopia and presbyopia in pigs.

Key features of the study:

This report provides an in-depth analysis of the global myopia & presbyopia eye drops market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global myopia & presbyopia eye drops market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals, LENZ Therapeutics, Visus Therapeutics, Ocuphire Pharma Inc., Eyenovia, Inc., Vyluma Inc., and Jawa Pharmaceuticals (India) Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global myopia & presbyopia eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global myopia & presbyopia eye drops market

Detailed Segmentation:

Global Myopia & Presbyopia Eye Drops Market, By Eye Drops:
- Atropine Drops
- Pipeline Products
  - CSF-1
  - AGN – 190584
  - Nyxol
  - UNR844-Cl
  - PRX-100
  - MicroLine
  - Others
Global Myopia & Presbyopia Eye Drops Market, By Indication:
- Myopia
- Presbyopia
Global Myopia & Presbyopia Eye Drops Market, By End User:
- Hospitals
- Ophthalmic Clinics
- Others
Global Myopia & Presbyopia Eye Drops Market, By Region:
- North America
  - By Eye Drops
    - Atropine Drops
    - Pipeline Products
      - CSF-1
      - AGN – 190584
      - Nyxol
      - UNR844-Cl
      - PRX-100
      - MicroLine
      - Others
  - By Indication
    - Myopia
    - Presbyopia
  - By End User
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - By Country
    - U.S.
    - Canada
- Latin America
  - By Eye Drops
    - Atropine Drops
    - Pipeline Products
      - CSF-1
      - AGN – 190584
      - Nyxol
      - UNR844-Cl
      - PRX-100
      - MicroLine
      - Others
  - By Indication
    - Myopia
    - Presbyopia
  - By End User
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - By Country
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Eye Drops
    - Atropine Drops
    - Pipeline Products
      - CSF-1
      - AGN – 190584
      - Nyxol
      - UNR844-Cl
      - PRX-100
      - MicroLine
      - Others
  - By Indication
    - Myopia
    - Presbyopia
  - By End User
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - By Country
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Eye Drops
    - Atropine Drops
    - Pipeline Products
      - CSF-1
      - AGN – 190584
      - Nyxol
      - UNR844-Cl
      - PRX-100
      - MicroLine
      - Others
  - By Indication
    - Myopia
    - Presbyopia
  - By End User
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Eye Drops
    - Atropine Drops
    - Pipeline Products
      - CSF-1
      - AGN – 190584
      - Nyxol
      - UNR844-Cl
      - PRX-100
      - MicroLine
      - Others
  - By Indication
    - Myopia
    - Presbyopia
  - By End User
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - By Country
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Eye Drops
    - Atropine Drops
    - Pipeline Products
      - CSF-1
      - AGN – 190584
      - Nyxol
      - UNR844-Cl
      - PRX-100
      - MicroLine
      - Others
  - By Indication
    - Myopia
    - Presbyopia
  - By End User
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - By Country/Region
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Orasis Pharmaceuticals*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AbbVie Inc. (Allergan)
- Novartis AG
- OSRX Pharmaceuticals
- LENZ Therapeutics
- Visus Therapeutics
- Ocuphire Pharma Inc.
- Eyenovia, Inc.
- Vyluma Inc.
- Jawa Pharmaceuticals (India) Pvt. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Eye Drops
  - Market Snapshot, By Indication
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunity
- Impact Analysis
- Industry Trends
- Mergers and Acquisitions
- Technology Overview
- Regulation Scenario
- Key Developments
- Recent Approvals
- PEST Analysis
- Epidemiology
- Pipeline Analysis
Global Myopia & Presbyopia Eye Drops Market– Impact of Coronavirus (COVID-19) Pandemic
- Impact of COVID-19 on Supply and Demand
- Impact of COVID-19 on Research and Development
- Impact of COVID-19 on Overall Healthcare Market
Global Myopia & Presbyopia Eye Drops Market, By Eye Drops, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- Atropine Drops
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Pipeline Products
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  - CSF-1
  - AGN-190584
  - Nyxol
  - UNR844-Cl
  - PRX-100
  - MicroLine
  - Others
Global Myopia & Presbyopia Eye Drops Market, By Indication, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- Myopia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Presbyopia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Global Myopia & Presbyopia Eye Drops Market, By End User, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2017 – 2028
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ophthalmic Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Global Myopia And Presbyopia Eye Drops Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, By Region, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, For Regions, 2017–2028
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
    - U.K.
    - Germany
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Countries/Region, 2017 – 2028, (US$ Mn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Orasis Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - AbbVie Inc. (Allergan)
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Novartis AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - OSRX Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - LENZ Therapeutics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Visus Therapeutics
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Ocuphire Pharma Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Eyenovia, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Vyluma Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Jawa Pharmaceuticals (India) Pvt. Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 25 market data tables and 30 figures on "Global Myopia And Presbyopia Eye Drops Market” - Global forecast to 2028

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now